Dectin-1 contributes to myocardial ischemia/reperfusion injury via immune cell regulation, presenting a potential therapeutic target.
Our results reveal a crucial role of Dectin-1 in the process of mouse myocardial IR injury and provide a new, clinically significant therapeutic target.
Fan et al. (Thu,) studied this question.